Zerumbone inhibits interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical cancer cells

International Immunopharmacology - Tập 12 - Trang 594-602 - 2012
Siddig Ibrahim Abdelwahab1, Ahmad Bustamam Abdul2, Zetty Nadia Mohd Zain2, A. Hamid A. Hadi3
1Department of Pharmacy, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience, University Putra Malaysia, 43400 UPM Serdang, Malaysia
3Department of Chemistry, Faculty of Science, University of Malaya, 50603, Kuala Lumpur, Malaysia

Tài liệu tham khảo

Sugarbaker, 2009, Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer, Curr Opin Obstet Gynecol, 21, 15, 10.1097/GCO.0b013e32831f8f32 Jasen, 2009, From the “silent killer” to the “whispering disease”: ovarian cancer and the uses of metaphor, Med History, 53, 489, 10.1017/S0025727300000521 Ozols, 2003, Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study, J Clin Oncol, 21, 3194, 10.1200/JCO.2003.02.153 Sankaranarayanan, 2009, HPV screening for cervical cancer in rural India, N Engl J Med, 360, 1385, 10.1056/NEJMoa0808516 Hodge, 2005, The role of IL-6 and STAT3 in inflammation and cancer, Eur J Cancer, 41, 2502, 10.1016/j.ejca.2005.08.016 2005, Song M, Kellum JA. Interleukin-6, Crit Care Med, 33, S463, 10.1097/01.CCM.0000186784.62662.A1 Ara, 2010, Interleukin-6 in bone metastasis and cancer progression, Eur J Cancer, 46, 1223, 10.1016/j.ejca.2010.02.026 Peters, 1996, The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6, J Exp Med, 183, 1399, 10.1084/jem.183.4.1399 Lazennec, 2008, Concise review: adult multipotent stromal cells and cancer: risk or benefit?, Stem Cells, 26, 1387, 10.1634/stemcells.2007-1006 Costanzo, 2005, Psychosocial factors and interleukin-6 among women with advanced ovarian cancer, Cancer, 104, 305, 10.1002/cncr.21147 Hirano, 1989, Interleukin-6: possible implications in human diseases, Int J Clin Lab Res, 19, 1, 10.1007/BF02871787 Wahab, 2009, In vitro ultramorphological assessment of apoptosis induced by zerumbone on (HeLa), microscope (Lieca attached with Q-Floro Software), 18, 19 Kim, 2009, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice, Int J Cancer, 124, 264, 10.1002/ijc.23923 Murakami, 2003, Suppression of dextran sodium sulfate-induced colitis in mice by zerumbone, a subtropical ginger sesquiterpene, and nimesulide: separately and in combination, Biochem Pharmacol, 66, 1253, 10.1016/S0006-2952(03)00446-5 Kitayama, 2001, Chemistry of zerumbone. 2. Regulation of ring bond cleavage and unique antibacterial activities of zerumbone derivatives, Biosci Biotechnol Biochem, 65, 2193, 10.1271/bbb.65.2193 Kitayama, 1999, Chemistry of zerumbone. 1. Simplified isolation, conjugate addition reactions, and a unique ring contracting transannular reaction of its dibromide, J Org Chem, 64, 2667, 10.1021/jo981593n Murakami, 2002, Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the alpha, beta unsaturated carbonyl group is a prerequisite, Carcinogenesis, 23, 795, 10.1093/carcin/23.5.795 Amslinger, 2010, The Tunable Functionality of alpha, beta Unsaturated Carbonyl Compounds Enables Their Differential Application in Biological Systems, ChemMedChem, 5, 351, 10.1002/cmdc.200900499 Bazzaro, 2011, Alpha, beta-Unsaturated Carbonyl System of Chalcone-Based Derivatives Is Responsible for Broad Inhibition of Proteasomal Activity and Preferential Killing of Human Papilloma Virus (HPV) Positive Cervical Cancer Cells, J Med Chem, 54, 449, 10.1021/jm100589p 2011, Abdelwahab SI, Abdul AB, Mohan S, Taha MME, Syam S, Ibrahim MY, et al. Zerumbone induces apoptosis in T-acute lymphoblastic leukemia cells, Leuk Res, 35, 268, 10.1016/j.leukres.2010.07.025 Abdul, 2009, Combination of zerumbone and cisplatin to treat cervical intraepithelial neoplasia in female balb/c mice, Int J Gynecol Cancer, 19, 1004, 10.1111/IGC.0b013e3181a83b51 Al-Zubairi, 2010, Evaluation of the genotoxicity of zerumbone in cultured human peripheral blood lymphocytes, Toxicol In Vitro, 24, 707, 10.1016/j.tiv.2010.01.011 Taha, 2010, Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet), Chem Biol Interact, 186, 295, 10.1016/j.cbi.2010.04.029 Jiang, 2011, Down-regulation of Expression of Interleukin-6 and its Receptor Results in Growth Inhibition of MCF-7 Breast Cancer Cells, Anticancer Res, 31, 2899 Baskic, 2006, Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide, Cell Biol Int, 30, 924, 10.1016/j.cellbi.2006.06.016 Wang, 2002, Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin, Cancer Lett, 183, 163, 10.1016/S0304-3835(02)00031-9 Ishihara, 2002, IL-6 in autoimmune disease and chronic inflammatory proliferative disease, Cytokine & Growth Factor Rev, 13, 357, 10.1016/S1359-6101(02)00027-8 Reed, 1992, Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells, J Endocrinol, 132, R5, 10.1677/joe.0.132R005 Falconer, 1994, Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer, Ann Surg, 219, 325, 10.1097/00000658-199404000-00001 Becker, 2004, TGF-[beta] Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling, Immunity, 21, 491, 10.1016/j.immuni.2004.07.020 Horiguchi, 2002, STAT3, but not ERKs, mediates the IL-6-R induced proliferation of renal cancer cells, ACHN and 769P, Kidney Int, 61, 926, 10.1046/j.1523-1755.2002.00206.x Moradi, 1993, Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor alpha in patients with ovarian epithelial cancer, Cancer, 72, 2433, 10.1002/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L Kurzrock, 2001, The role of cytokines in cancer-related fatigue, Cancer, 92, 1684, 10.1002/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z Kelly, 2006, TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer, Cancer Res, 66, 3859, 10.1158/0008-5472.CAN-05-3948 Iyori, 2011, TRAIL/DR5 Plays a Critical Role in NK Cell-Mediated Negative Regulation of Dendritic Cell Cross-Priming of T Cells, J Immunol, 187, 3087, 10.4049/jimmunol.1003879 Shust, 2010, Female genital tract secretions inhibit herpes simplex virus infection: correlation with soluble mucosal immune mediators and impact of hormonal contraception, Am J Reprod Immunol (New York, NY:1989), 63, 110, 10.1111/j.1600-0897.2009.00768.x Beetz, 2000, NF-KB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells, Int J Radiat Biol, 76, 1443, 10.1080/09553000050176207 Vaux, 1988, Bcl-2 and cell survival, Nature, 335, 440, 10.1038/335440a0